Unique histological changes in lung metastases of osteosarcoma patients following therapy with liposomal muramyl tripeptide (CGP 19835A lipid) Eugenie S. KleinermanAustin K. RaymondIsaiah J. Fidler Original articles Pages: 211 - 220
Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels P. BasseR. B. HerbermanR. H. Goldfarb Original articles Pages: 221 - 227
Effect of anticancer drugs on the release of interleukin-6 in vitro S. I. HasanBarbara A. D. BlaneyJ. L. Turk Original articles Pages: 228 - 232
Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells Joep J. BergersWillem Den OtterDaan J. A. Crommelin Original articles Pages: 233 - 240
Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype Licia RivoltiniFlavio ArientiGiorgio Parmiani Original articles Pages: 241 - 251
Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984 A. H. G. J. SchrijversM. GerretsenG. A. M. S. van Dongen Original articles Pages: 252 - 258
Potentiated lymphokine-activated killer cell activity generated by low-dose interleukin-2 and mismatched double-stranded RNA Howard R. HubbellGeorge D. GibsonRobert D. Bigler Original articles Pages: 259 - 264
Effect of monoclonal antibodies to early pregnancy factor (EPF) on the in vivo growth of transplantable murine tumours K. A. QuinnH. Morton Original articles Pages: 265 - 271
Phorbol 12-myristate 13-acetate induces resistance of human melanoma cells to natural-killer-and lymphokine-activated-killer-mediated cytotoxicity Pierpaolo CorrealeAntonio ProcopioAngelo Raffaele Bianco Original articles Pages: 272 - 278
1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)/interleukin-2 chemoimmunotherapy of murine L1210 leukemia Anthony L. FaroneDonald C. Cox Short communication Pages: 279 - 281
